Filter
402
Text search:
patent
Featured
Recommendations
37
New Publications
101
Language
Document type
No document type
194
Studies & Reports
82
Guidelines
68
Manuals
25
Strategic & Response Plan
14
Fact sheets
10
Training Material
5
Infographics
2
Situation Updates
1
Resource Platforms
1
Countries / Regions
India
33
Nigeria
31
Global
13
Kenya
9
South Africa
7
Uganda
6
Tanzania
5
Malawi
5
Sierra Leone
4
Liberia
4
Ethiopia
4
Ghana
4
Nepal
4
Ukraine
4
Myanmar / Burma
4
Latin America and the Carribbean
4
Asia
4
Indonesia
3
Western and Central Europe
3
Cameroon
2
Zimbabwe
2
Germany
2
Zambia
2
Rwanda
2
Bangladesh
2
Lesotho
2
East and Southern Africa
2
West and Central Africa
2
Africa
2
Eastern Europe
2
Congo, Democratic Republic of
1
Philippines
1
Pakistan
1
Cambodia
1
Thailand
1
China
1
Mozambique
1
Papua New Guinea
1
Sudan
1
Botswana
1
Venezuela
1
Laos
1
Tajikistan
1
Georgia
1
Vietnam
1
North America
1
Authors & Publishers
Publication Years
Category
Countries
134
Clinical Guidelines
68
Women & Child Health
28
Public Health
19
Pharmacy & Technologies
19
Key Resources
10
Capacity Building
4
Annual Report MEDBOX
1
Toolboxes
HIV
53
Pharmacy
26
COVID-19
25
AMR
23
TB
19
Caregiver
16
NTDs
13
Global Health Education
9
Malaria
9
NCDs
8
Mental Health
7
Rapid Response
5
Planetary Health
4
Health Financing Toolbox
4
Conflict
3
Refugee
3
Disability
2
Ebola & Marburg
2
Natural Hazards
1
Zika
1
Specific Hazards
1
Social Ethics
1
Language influences the way we think, how we perceive reality, and how we behave. With respect to HIV, language can embody stigma and discrimination, which impacts access to testing, acquisition of HIV, and engagement with treatment. Language plays a role in supporting respect and empowerment of ind
...
The purpose of this TPP is to communicate the minimum and ideal characteristics desired to meet the need for discriminating low levels of risk for transmission, i.e. targeted prevalence thresholds in the surveyed areas. An in vitro diagnostic test is needed for the detection of analyte(s) specific t
...
WHO Model Formulary for Children
recommended
WHO Model Formulary for children based on the Second Model List of Essential Medicines for Children 2009.
In 2007, the World Health Assembly passed a Resolution titled ‘Better Medicines for Children’. This resolution recognized the need for research and development into medicines for children,
...
SITUATION ANALYSIS AND RECOMMENDATIONS
This Training module on malaria elimination has been developed by WHO to support health professionals in planning, managing, monitoring and evaluating malaria elimination programmes.
Supporting exercises: These files are necessary for participants to complete a number of exercises listed in the man
...
Treatment Recommendations for Adult Inpatients
Antimicrobial resistance is a global crisis that threatens a century of progress in health and achievement of the Sustainable Development Goals. There is no time to wait. Unless the world acts urgently, antimicrobial resistance will have disastrous impact within a generation.
PHARMA’S RESPONSE TO THE COVID-19 VACCINES CRISIS. Update Feb., 14, 2022. In September 2021, Amnesty International published A Double Dose of Inequality, which assessed the extent to which the pharmaceutical industry was restricting access to Covid-19 vaccines. This report updates that assessment
...
Sepsis remains a leading cause of mortality and morbidity, especially during the first five days of life and in low and middle-income countries (LMIC) [1]. Hospital infection also remains a major cause of mortality in children despite progress encountered in the last decades.
Global UNIDO Project: Strengthening the local production of essential generic drugs in the least developed and developing countries
This document is for humanitarian health actors working at national and sub-national level in countries facing humanitarian emergencies. It applies to Health Cluster partners, including governmental and non-governmental health service providers.
Based on the IASC Guidelines on Mental Health and Psy
...
Medicines and Allied Substances [No. 3 of 2013 47 | An Act to continue the existence of the Pharmaceutical Regulatory Authority and re-name it as the Zambia Medicines Regulatory Authority; provide for the functions and powers of the Authority; provide for the registration and regulation of pharmacie
...
Economic Issues, Policies and Option for Action
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys
...
Time has seen management for Cystic Fibrosis (CF) advance drastically, most recently in the development of the disease-modifying triple combination therapy ivacaftor/tezacaftor/elexacaftor. There is currently limited evidence regarding both the global epidemiology of CF and access to this transforma
...
